Feed / HRMY

Harmony Biosciences Holdings, I

HRMY

Healthcare · 34.78 -2.1% today

Jodie read · what matters now

Harmony Biosciences Holdings, I is being tracked across filings, market groups, and disclosed business relationships.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to HRMY, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections9 verified links6 additional receipts in Pro
Organic co-movement groupRare Neurological Therapies · LeaderLast observed group; it is between live snapshots · See active groups →

Who this business touches

The relationships behind HRMY

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ALKSAlkermes plcsupplierFull receipt with Pro →
JPMJP Morgan Chase & Co.lenderFull receipt with Pro →

Depended on by

AXSMAxsome Therapeutics, Inc.competitorFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 6 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

HRMY is currently a Leader in the organic co-movement group Rare Neurological Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for HRMY; it is not active in the latest market snapshot.

Theme membership history

No durable theme membership has been observed for this name yet.